Status: Finalised First registered on: 27/10/2015
Last updated on: 29/10/2018
1. Study identification
EU PAS Register NumberEUPAS11410
Official titleAsthma management in France and the United Kingdom
Study title acronym
Study typeObservational study
Brief description of the studyThis study will compare asthma management between patients in the United Kingdom and in France, in particular with regards to "at-risk" treatment patters. Two successive cohorts of persistent patients will be defined in 2007/2008 and in 2013/2014. Comparisons of asthma management between 2007 and 2013 will be made within countries to determine if there are any changes in "at-risk" management. Between countries, comparisons will be made to determine if there are differences in managements. For the latter analysis, only the 2013/2014 cohort will be used.
Was this study requested by a regulator?Don't know
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsOPRI Pte Ltd
Department/Research groupResearch in Real Life Ltd
Organisation/affiliationOPRI Pte Ltd
Website/Homepagewww.rirl.org
Details of (Primary) lead investigator
Title Dr
Last name Van Ganse
First name David
Is this study being carried out with the collaboration of a research network?
Yes

Respiratory Effectiveness Group (REG)
Other centres where this study is being conducted
Multiple centres

In total how many centres are involved in this Study?2

OPRI Pte Ltd
Countries in which this study is being conducted
International study

France
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed30/10/201501/10/2015
Start date of data collection30/10/201507/10/2015
Start date of data analysis02/11/201502/11/2015
Date of interim report, if expected
Date of final study report29/01/201613/10/2016
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherClaude-Bernard-Lyon1 University100
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Van Ganse
First name David
Address line 111 rue Guillaume Paradin
Address line 2 
Address line 3 
CityLyon 
Postcode 
CountryFrance
Phone number (incl. country code)33478778609 
Alternative phone number 
Fax number (incl. country code) 
Email address eric.van-ganse@univ-lyon1.fr
Public Enquiries
Title Dr 
Last name Van Ganse 
First name David 
Address line 111 rue Guillaume Paradin 
Address line 2 
Address line 3 
CityLyon 
Postcode 
CountryFrance 
Phone number (incl. country code)33478778609 
Alternative phone number 
Fax number (incl. country code) 
Email address eric.van-ganse@univ-lyon1.fr 
Top